|
⚲
|
| Keyboard |
| Lux Venture Partners II LP
✚
|
|
|---|---|
| CIK # | 0001592756 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001592756] | |
| 4 | [0001592756] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Everspin Technologies Inc MRAM
Common Stock
|
2016-10-13 | Conversion | 219,916 | ||
|
Everspin Technologies Inc MRAM
Common Stock
|
2016-10-13 | Conversion | 131,719 | $6.40 | 843,002 |
|
Everspin Technologies Inc MRAM
Common Stock
|
2016-10-13 | Conversion | 89,946 | $6.40 | 575,654 |
|
Everspin Technologies Inc MRAM
Common Stock
|
2016-10-13 | Buy | 137,420 | $8.00 | 1,099,360 |
|
Everspin Technologies Inc MRAM
Common Stock
|
2016-10-13 | Conversion | 118,606 | ||
|
Everspin Technologies Inc MRAM
5% Convertible Subordinated Promissory Note · derivative
|
2016-10-13 | Conversion | $0.00 | ||
|
Everspin Technologies Inc MRAM
5% Convertible Subordinated Promissory Note · derivative
|
2016-10-13 | Conversion | $0.00 | ||
|
Everspin Technologies Inc MRAM
Series B Preferred Stock · derivative
|
2016-10-13 | Conversion | 118,606 | $0.00 | |
|
Everspin Technologies Inc MRAM
Series A Preferred Stock · derivative
|
2016-10-13 | Conversion | 219,916 | $0.00 | |
|
Genocea Biosciences Inc GNCA
Common Stock
|
2014-02-10 | Conversion | 178,732 | ||
|
Genocea Biosciences Inc GNCA
Series B Preferred Stock · derivative
|
2014-02-10 | Conversion | 3,207,794 | $0.00 | |
|
Genocea Biosciences Inc GNCA
Common Stock
|
2014-02-10 | Conversion | 705,357 | ||
|
Genocea Biosciences Inc GNCA
Common Stock
|
2014-02-10 | Option exercise | 15,852 | ||
|
Genocea Biosciences Inc GNCA
Common Stock
|
2014-02-10 | Conversion | 428,502 | ||
|
Genocea Biosciences Inc GNCA
Common Stock
|
2014-02-10 | Conversion | 269,561 | ||
|
Genocea Biosciences Inc GNCA
Seed Preferred Stock · derivative
|
2014-02-10 | Conversion | 2,126,923 | $0.00 | |
|
Genocea Biosciences Inc GNCA
Series A Preferred Stock · derivative
|
2014-02-10 | Conversion | 8,393,754 | $0.00 | |
|
Genocea Biosciences Inc GNCA
Warrants to purchase Series A Preferred Stock · derivative
|
2014-02-10 | Option exercise | 587,931 | $0.00 | |
|
Genocea Biosciences Inc GNCA
Series C Preferred Stock · derivative
|
2014-02-10 | Conversion | 5,099,196 | $0.00 |